Makis joined Innovis Pharma in 2018 as President & Managing Director. Prior to that he served for many years as Country Manager for Teva Greece & Cyprus (previously Specifar Pharmaceuticals).
His long tenure in Specifar started in the position of Corporate Development Director, preceding the acquisition of the company by Watson Pharmaceuticals. He was then appointed head of the group upon its merger with Actavis Pharmaceuticals and led the Greek affiliate during all the M&A developments that followed (Allergan, Teva). Before that he was leading Opinion S.A., a marketing research agency, as Managing Partner.
Makis holds a BSc. in Business Administration from Boston University and an MSc. in Corporate Finance from Bentley University.